These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 14575109)

  • 1. Development of hemagglutinin subtype-specific reference antisera by DNA vaccination of chickens.
    Lee CW; Senne DA; Suarez DL
    Avian Dis; 2003; 47(3 Suppl):1051-6. PubMed ID: 14575109
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and application of reference antisera against 15 hemagglutinin subtypes of influenza virus by DNA vaccination of chickens.
    Lee CW; Senne DA; Suarez DL
    Clin Vaccine Immunol; 2006 Mar; 13(3):395-402. PubMed ID: 16522783
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Strategies for improving the efficacy of a H6 subtype avian influenza DNA vaccine in chickens.
    Shan S; Jiang Y; Bu Z; Ellis T; Zeng X; Edwards J; Tian G; Li Y; Ge J; Chen H; Fenwick S
    J Virol Methods; 2011 May; 173(2):220-6. PubMed ID: 21333689
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improved immune responses against avian influenza virus following oral vaccination of chickens with HA DNA vaccine using attenuated Salmonella typhimurium as carrier.
    Jazayeri SD; Ideris A; Zakaria Z; Yeap SK; Omar AR
    Comp Immunol Microbiol Infect Dis; 2012 Sep; 35(5):417-27. PubMed ID: 22512819
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced protective efficacy of H5 subtype avian influenza DNA vaccine with codon optimized HA gene in a pCAGGS plasmid vector.
    Jiang Y; Yu K; Zhang H; Zhang P; Li C; Tian G; Li Y; Wang X; Ge J; Bu Z; Chen H
    Antiviral Res; 2007 Sep; 75(3):234-41. PubMed ID: 17451817
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Generation of reassortant influenza vaccines by reverse genetics that allows utilization of a DIVA (Differentiating Infected from Vaccinated Animals) strategy for the control of avian influenza.
    Lee CW; Senne DA; Suarez DL
    Vaccine; 2004 Aug; 22(23-24):3175-81. PubMed ID: 15297071
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protection of chickens against highly lethal H5N1 and H7N1 avian influenza viruses with a recombinant fowlpox virus co-expressing H5 haemagglutinin and N1 neuraminidase genes.
    Qiao CL; Yu KZ; Jiang YP; Jia YQ; Tian GB; Liu M; Deng GH; Wang XR; Meng QW; Tang XY
    Avian Pathol; 2003 Feb; 32(1):25-32. PubMed ID: 12745375
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Experimental challenge of chicken vaccinated with commercially available H5 vaccines reveals loss of protection to some highly pathogenic avian influenza H5N1 strains circulating in Hong Kong/China.
    Connie Leung YH; Luk G; Sia SF; Wu YO; Ho CK; Chow KC; Tang SC; Guan Y; Malik Peiris JS
    Vaccine; 2013 Aug; 31(35):3536-42. PubMed ID: 23791547
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protection of chickens against H5N1 highly pathogenic avian influenza virus infection by live vaccination with infectious laryngotracheitis virus recombinants expressing H5 hemagglutinin and N1 neuraminidase.
    Pavlova SP; Veits J; Keil GM; Mettenleiter TC; Fuchs W
    Vaccine; 2009 Jan; 27(5):773-85. PubMed ID: 19041677
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fusion of HSP70 gene of Mycobacterium tuberculosis to hemagglutinin (H5) gene of avian influenza virus in DNA vaccine enhances its potency.
    Rasoli M; Omar AR; Aini I; Jalilian B; Syed Hassan SH; Mohamed M
    Acta Virol; 2010; 54(1):33-9. PubMed ID: 20201612
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improvements to the hemagglutination inhibition test for serological assessment of recombinant fowlpox-H5-avian-influenza vaccination in chickens and its use along with an agar gel immunodiffusion test for differentiating infected from noninfected vaccinated animals.
    Swayne DE; Avellaneda G; Mickle TR; Pritchard N; Cruz J; Bublot M
    Avian Dis; 2007 Sep; 51(3):697-704. PubMed ID: 17992929
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DNA vaccine encoding avian influenza virus H5 and Esat-6 of Mycobacterium tuberculosis improved antibody responses against AIV in chickens.
    Oveissi S; Omar AR; Yusoff K; Jahanshiri F; Hassan SS
    Comp Immunol Microbiol Infect Dis; 2010 Dec; 33(6):491-503. PubMed ID: 19781778
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Strategies to improve protection against low-pathogenicity H7 avian influenza virus infection using DNA vaccines.
    Cherbonnel M; Rousset J; Jestin V
    Avian Dis; 2003; 47(3 Suppl):1181-6. PubMed ID: 14575138
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of a recombinant ELISA using yeast (Pichia pastoris)-expressed polypeptides for detection of antibodies against avian influenza A subtype H5.
    Shehata AA; Fiebig P; Sultan H; Hafez M; Liebert UG
    J Virol Methods; 2012 Mar; 180(1-2):18-25. PubMed ID: 22197190
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase 1 clinical trials of the safety and immunogenicity of adjuvanted plasmid DNA vaccines encoding influenza A virus H5 hemagglutinin.
    Smith LR; Wloch MK; Ye M; Reyes LR; Boutsaboualoy S; Dunne CE; Chaplin JA; Rusalov D; Rolland AP; Fisher CL; Al-Ibrahim MS; Kabongo ML; Steigbigel R; Belshe RB; Kitt ER; Chu AH; Moss RB
    Vaccine; 2010 Mar; 28(13):2565-72. PubMed ID: 20117262
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytotoxicity and immunological responses following oral vaccination of nanoencapsulated avian influenza virus H5 DNA vaccine with green synthesis silver nanoparticles.
    Jazayeri SD; Ideris A; Zakaria Z; Shameli K; Moeini H; Omar AR
    J Control Release; 2012 Jul; 161(1):116-23. PubMed ID: 22549012
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recombinant paramyxovirus type 1-avian influenza-H7 virus as a vaccine for protection of chickens against influenza and Newcastle disease.
    Swayne DE; Suarez DL; Schultz-Cherry S; Tumpey TM; King DJ; Nakaya T; Palese P; Garcia-Sastre A
    Avian Dis; 2003; 47(3 Suppl):1047-50. PubMed ID: 14575108
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative efficacy of North American and antigenically matched reverse genetics derived H5N9 DIVA marker vaccines against highly pathogenic Asian H5N1 avian influenza viruses in chickens.
    Jadhao SJ; Lee CW; Sylte M; Suarez DL
    Vaccine; 2009 Oct; 27(44):6247-60. PubMed ID: 19686695
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Seasonal influenza vaccination is the strongest correlate of cross-reactive antibody responses in migratory bird handlers.
    Oshansky CM; Wong SS; Jeevan T; Smallwood HS; Webby RJ; Shafir SC; Thomas PG
    mBio; 2014 Dec; 5(6):e02107. PubMed ID: 25491354
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protective efficacy of H7 subtype avian influenza DNA vaccine.
    Jiang Y; Zhang H; Wang G; Zhang P; Tian G; Bu Z; Chen H
    Avian Dis; 2010 Mar; 54(1 Suppl):290-3. PubMed ID: 20521647
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.